We will see by this time tomorrow.
Up only 3 bucks. Other than the hopeful shorts, no one seems to want to sell this stock. At one point this morning,I noted that the bid was 101.22 and the ask was 101.73. If I were short, gaps like that would be disquieting.
All RAD has to do is make enough money to stay in business. Ultimately, either WAG or CVS will have to buy them.
Given California tax law, it's risky to exercise a stock option and not sell the stock. The difference between the exercised price and fair market value is taxable as ordinary income --- which in the higher brackets is about 13%. Plus, for many, a state AMT tax. Yousell the stock to be sure of havingenough profit in the bank to pay the state (and the Feds) their cut.
Yes. The odd thing was how few of the major funds had stakes in this. Adage was buying up sizable chunks,but Baker Brothers Advisors, probably the premier biotech fund, had only a tiny stake. What reassured me was Auerbach's attitude in the analyst presentations, which bordered on arrogant. He certainly didn't waste any time flattering them. The strength of the rally has been remarkable. Continued good luck to you.
The options tell you that this is not possible (the 20 points, not the puppy). However, if we can break back through 100, we should take out some of the shorts' stops, which could be good for a little run.
No reason for anyone with a modicum of sense to linger here. Have at it, loonies!
My inclination is to add cautiously, looking to double up, with 50% added by yearend,the other 50% in the first two weeks of 2014. The hopeful thing here is the growing numbers of shorts.
Your friends are no indication. Will definitely test 90's again tomorrow. If it moves up, I think it will be walked up slowly. I will continue to add cautiously.
The problem with Provenge - which obviously the market has figured out a long time ago - is that it is not a drug at all, but a custom-made vaccine which is very expensive to create and only marginally beneficial to a few.
On the other hand, if CC confirms what the tape is telling us .....? I don't know whether you have ever heard Auerbach and his team (virtually all of whom came over with him from Cougar, or Lynx, or whatever the previous company was), but they are impressive.
Close enough. But it will take a breather at some point. Enter, but enter cautiously. If this drug is everything we think it is, there's plenty of room on the upside.
PS Aren't you the poster who continually changes your id, but whose posts are always full of obscenities and fantasies of anal rape? With a little soupcon of anti-Semitism thrown in? Forget what I said. Double up here.
Get in line with the other victims. See if you can get this straight: This is a closely held stock. There is no mob of retail longs here hoping to make a couple of bucks. This is a stock which will ride up on the backs of ignorant shorts.
jgm, you are the voice of reason (and you know how far that will get you.) Anyway, thanks again for your presence here.
Given California tax laws, it makes sense to exercise options when they get into the money. I don't know what took him this long. There are plenty more where those came from.